Page
%P
![Loading...](https://link.springer.com/static/c4a417b97a76cc2980e3c25e2271af3129e08bbe/images/pdf-preview/spacer.gif)
-
Chapter
Transgenic Expression of IL-2 in Peripheral Neuroectodermal Malignancies of Childhood: In Vitro and In Vivo Effects on Lymphocyte Activation and Tumor Lysis
Posttransplantational adjuvant interleukin-2 (IL-2) therapy has previously been shown to improve the prognosis of patients with Ewing tumors. This has been attributed to a stimulation of the immune system and ...